找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Medicines For Women; Mira Harrison-Woolrych Book 2015 Springer International Publishing Switzerland 2015 Efficacy and safety medicines for

[復(fù)制鏈接]
查看: 52822|回復(fù): 55
樓主
發(fā)表于 2025-3-21 18:39:10 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Medicines For Women
編輯Mira Harrison-Woolrych
視頻videohttp://file.papertrans.cn/630/629506/629506.mp4
概述Covers key issues with women‘s medicines.Discusses specific women‘s medicines including products where there have been key developments and/or pharmacovigilance issues in recent years.Addresses prescr
圖書(shū)封面Titlebook: Medicines For Women;  Mira Harrison-Woolrych Book 2015 Springer International Publishing Switzerland 2015 Efficacy and safety medicines for
描述.In this definitive new text, the major medicines, devices and vaccines used by women worldwide are brought together for the first time in a single volume.?Written and edited by international experts with an evidence-based approach, the book offers a comprehensive summary of all the key areas of women’s medicines. In the first part, issues relating to female drug exposure and considerations for prescribing for subgroups of women - for example during pregnancy and lactation - are presented in the context of contemporary clinical practice.?In the second part, specific groups of pharmaceutical products are reviewed, including oral contraceptives, emergency contraception, treatment of chronic pelvic pain, hormone replacement therapy, bisphosphonates, herbal medicines for women, contraceptive devices and human papilloma virus (HPV) vaccines.? Every chapter reviews and summarises the efficacy and safety of each group of products and concludes with a useful set of clinical take home messages.?In the third part, broader perspectives are presented - from a primary care overview of prescribing for women, through to regulatory, political and religious aspects, including issues with women’s me
出版日期Book 2015
關(guān)鍵詞Efficacy and safety medicines for women; Medicines for women; Pharmacovigilance; Prescribing for female
版次1
doihttps://doi.org/10.1007/978-3-319-12406-3
isbn_softcover978-3-319-35015-8
isbn_ebook978-3-319-12406-3
copyrightSpringer International Publishing Switzerland 2015
The information of publication is updating

書(shū)目名稱Medicines For Women影響因子(影響力)




書(shū)目名稱Medicines For Women影響因子(影響力)學(xué)科排名




書(shū)目名稱Medicines For Women網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Medicines For Women網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Medicines For Women被引頻次




書(shū)目名稱Medicines For Women被引頻次學(xué)科排名




書(shū)目名稱Medicines For Women年度引用




書(shū)目名稱Medicines For Women年度引用學(xué)科排名




書(shū)目名稱Medicines For Women讀者反饋




書(shū)目名稱Medicines For Women讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:17:16 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:18:04 | 只看該作者
地板
發(fā)表于 2025-3-22 07:27:05 | 只看該作者
Bisphosphonates for OsteoporosisBisphosphonates are among the most widely used medicines for the treatment of bone diseases. They are generally well tolerated, serious adverse events are rare and the risk-benefit risk profile in osteoporotic patients is overwhelmingly favourable in most better option.
5#
發(fā)表于 2025-3-22 10:04:56 | 只看該作者
https://doi.org/10.1007/978-3-319-12406-3Efficacy and safety medicines for women; Medicines for women; Pharmacovigilance; Prescribing for female
6#
發(fā)表于 2025-3-22 14:18:33 | 只看該作者
7#
發(fā)表于 2025-3-22 19:02:49 | 只看該作者
8#
發(fā)表于 2025-3-23 01:08:47 | 只看該作者
9#
發(fā)表于 2025-3-23 04:22:22 | 只看該作者
10#
發(fā)表于 2025-3-23 08:08:08 | 只看該作者
ce computing and the computing power available using standalone single-processor machines. Traffic in networks connecting such systems is typically characterized by its distribution in time and space. Three approaches can be applied to determine the related network performance: measurement, simulati
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 20:38
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
玛曲县| 孝感市| 寻甸| 舒兰市| 荥经县| 东阿县| 广西| 望谟县| 琼结县| 瑞丽市| 隆安县| 宁波市| 黔西| 福海县| 侯马市| 文水县| 青阳县| 游戏| 峨山| 射阳县| 革吉县| 梅河口市| 松原市| 石河子市| 锦州市| 格尔木市| 炎陵县| 旅游| 卢龙县| 剑河县| 广丰县| 泰顺县| 苗栗县| 含山县| 梅州市| 栖霞市| 麟游县| 德惠市| 新营市| 定日县| 晋中市|